Tang et al. investigated the local delivery of B7-H3-targeted CAR-T cells in a patient with recurrent anaplastic meningioma and reported that the treatment demonstrated both tolerability and local bioactivity, with decreased B7-H3 expression detected in the cavity after treatment [250]. This evidence concerns the gene CD276 and anaplastic meningioma.